Jubilant Biosys names new chief executive officer
8 September 2021 -

Jubilant Biosys Limited, an India-based pharmaceuticals, contract research and development, and proprietary novel drugs company, announced on Wednesday that it has named Giuliano Perfetti as its new chief executive officer.

Perfetti has over 20 years of experience in various companies and global markets, and experience in strategy, sales, marketing and business development. He has headed business transformation and expansion programs for firms such as Accenture and Astrazeneca, among others. He has served as chief commercial officer at Fabbrica Italiana Sintetici.

Shyam S Bhartia, chairman, and Hari S Bhartia, co-chairman and managing director of Jubilant Pharmova, said, 'Jubilant Biosys is pleased to bring Giuliano on board at a time when we are investing in infrastructure and new capacities make rapid progress in expanding our drug discovery services and CDMO business.'